<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01088204</url>
  </required_header>
  <id_info>
    <org_study_id>NCCCTS-09-448</org_study_id>
    <nct_id>NCT01088204</nct_id>
  </id_info>
  <brief_title>Feasibility Study of Laparoscopy-assisted D2 Distal Gastrectomy to Treat Advanced Gastric Cancer</brief_title>
  <acronym>COACT_1001</acronym>
  <official_title>A Multicenter Randomized Phase II Clinical Trial of Laparoscopy Assisted Versus Open Distal Gastrectomy With D2 Lymph Node Dissection for Advanced Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the oncological feasibility of laparoscopy-assisted
      distal gastrectomy with D2 lymph node dissection for advanced gastric cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To test oncological feasibility, compliance of nodal dissection was selected as a primary end
      point. When there are more than two missing nodal station(no lymph nodes in dissected area),
      it is defined as a non-compliant nodal dissection. Other secondary outcomes will be
      supplementary to evaluate feasibility of D2 dissection.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>noncompliance rate</measure>
    <time_frame>postoperative 1 week</time_frame>
    <description>A Case will be designated as &quot;noncompliant&quot; when there are more than one missing lymph node station according to the guidelines of &quot;The Japanese Research Society for Gastric Cancer&quot; (JRSGC) lymph node grouping</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative surgical complications</measure>
    <time_frame>postoperative 1 day, 1 week, 1 months, 3 months, 6 months, 12 months</time_frame>
    <description>Major and minor, and short term and long term complications related with surgery will be monitored and recorded according to classification of Accordion Severity Classification of Postoperative Complications; Expanded Classification.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>operating time</measure>
    <time_frame>operation day</time_frame>
    <description>From skin incision to wound closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to first flatus</measure>
    <time_frame>postoperative 1 week</time_frame>
    <description>the day when a patient relieve gastrointestinal gas</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of retrieved lymph nodes</measure>
    <time_frame>postoperative 1 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of retrieved lymph nodes at each stations</measure>
    <time_frame>postoperative 1 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proximal resection margin</measure>
    <time_frame>postoperative 1 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>distal resection margin,</measure>
    <time_frame>postoperative 1 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>unanimity rate of 3 randomly assigned laparoscopic gastric cancer surgeons</measure>
    <time_frame>postoperative 3 months</time_frame>
    <description>Three randomly assigned laparoscopic gastric cancer surgeons would evaluate the uneditted video and photoes and validate the lymph node dissection according to each stations.When the three surgeons agree that D2 lymph node dissection was performed, it is considered as unanimity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3-year disease free survival</measure>
    <time_frame>postoperative 3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">204</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>open distal gastrectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>open distal gastrectomy with D2 lymph node dissection for patients with advanced gastric cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laparoscopy assisted distal gastrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>laparoscopy assisted distal gastrectomy with D2 lymph node dissection for patients with advanced gastric cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopy assisted distal gastrectomy</intervention_name>
    <description>laparoscopy assisted distal gastrectomy with D2 lymph node dissection for patients with advanced gastric cancer</description>
    <arm_group_label>laparoscopy assisted distal gastrectomy</arm_group_label>
    <other_name>LADG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>open distal gastrectomy</intervention_name>
    <description>open distal gastrectomy with D2 lymph node dissection for patients with advanced gastric cancer</description>
    <arm_group_label>open distal gastrectomy</arm_group_label>
    <other_name>ODG</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  histologically proven primary gastric adenocarcinoma

          -  T2 or T3 or T4a, N0 or N1 or N2 or N3a (AJCC 7th), which is assessed by computed
             tomography (CT) scan - mid 1/3 or low 1/3 location

          -  No evidence of other distant metastasis

          -  not stump carcinoma,(vi) aged 20-80 year old

          -  performance status (PS) of 0 or 1 on Eastern Cooperative Oncology Group (ECOG) scale

          -  no prior treatment of chemotherapy or radiation therapy against any other
             malignancies, and no prior treatment for gastric cancer including endoscopic mucosal
             resection

          -  adequate organ functions defined as indicated below:

               -  WBC 3000/mm3, WBC 12 000/mm3

               -  Hb 8.0 g/dl without any transfusion 2 weeks before enrollment

               -  Plt 100 000/mm3

               -  AST 100 IU/l

               -  ALT 100 IU/l

               -  T.Bil 2.0 mg/dl

               -  written informed consent

        Exclusion Criteria:

          -  active double cancer (synchronous double cancer and metachronous double cancer within
             five disease-free years), excluding carcinoma in situ (lesions equal to
             intraepithelial or intramucosal cancer)

          -  pregnant or breast-feeding women

          -  severe mental disorder

          -  systemic administration of corticosteroids

          -  unstable angina or myocardial infarction within 6 months of the trial

          -  unstable hypertension

          -  severe respiratory disease requiring continuous oxygen therapy

          -  previous upper abdominal surgery except laparoscopic cholecystectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young-Woo Kim, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Center, Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chonnam National University Hwasun Hospital</name>
      <address>
        <city>Hwasun</city>
        <state>Chollanam Do</state>
        <zip>519-763</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Goyang</city>
        <state>Gyeonggi-do</state>
        <zip>411-764</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gyengsang National University Hospital</name>
      <address>
        <city>Jinju</city>
        <state>Gyeongsangnam -Do</state>
        <zip>660-702</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyungpook national university hospital</name>
      <address>
        <city>Dae Gu</city>
        <zip>700-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Konyang University Hospital</name>
      <address>
        <city>Dae Jeon</city>
        <zip>302-718</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dae Gu Veterans Hospital</name>
      <address>
        <city>Daegu</city>
        <zip>704-802</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kosin University Gospel Hospital</name>
      <address>
        <city>Pusan</city>
        <zip>602-702</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://ncc.re.kr</url>
    <description>National Cancer Center web site</description>
  </link>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2010</study_first_submitted>
  <study_first_submitted_qc>March 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2010</study_first_posted>
  <last_update_submitted>October 5, 2015</last_update_submitted>
  <last_update_submitted_qc>October 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Young-Woo Kim</investigator_full_name>
    <investigator_title>Head of Department of Gastric Cancer Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

